Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) EBITDA Margin (2016 - 2025)

iBio (IBIO) has disclosed EBITDA Margin for 16 consecutive years, with 5735.0% as the latest value for Q3 2025.

  • Quarterly EBITDA Margin changed N/A to 5735.0% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 8260.0% through Dec 2025, down 415653.0% year-over-year, with the annual reading at 4650.5% for FY2025, 274239.0% up from the prior year.
  • EBITDA Margin for Q3 2025 was 5735.0% at iBio, down from 2599.0% in the prior quarter.
  • The five-year high for EBITDA Margin was 377.11% in Q1 2022, with the low at 10206.0% in Q3 2023.
  • Average EBITDA Margin over 5 years is 3570.15%, with a median of 2182.0% recorded in 2024.
  • Peak annual rise in EBITDA Margin hit 329176bps in 2021, while the deepest fall reached -453146bps in 2021.
  • Over 5 years, EBITDA Margin stood at 6220.24% in 2021, then soared by 94bps to 377.11% in 2022, then plummeted by -2606bps to 10206.0% in 2023, then soared by 79bps to 2182.0% in 2024, then tumbled by -163bps to 5735.0% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 5735.0%, 2599.0%, and 2182.0% for Q3 2025, Q2 2025, and Q4 2024 respectively.